during the visit. There were no other physicians or physician extenders present at
Facility B.

12. | Employee A is the office administrator at Facility B.

13. During the November 1, 2017 site visit, the Respondent acknowledged to Board
staff that he was aware that his medical license had expired.

14. During the November 1, 2017 site visit, the Respondent acknowledged that he
had provided medical care to four to five patients on November 1, 2017.°

15. During the November 1, 2017 site visit, the Respondent stated that he had also
rendered medical care to approximately 20 patients at Facility B the day before, on
October 30, 2017.

FEDERAL INDICTMENT

16. On or about November 29, 2017, the Respondent was indicted in the United
States District Court for the District of Maryland pursuant to 21 U.S.C. § 841(a)(1),
prohibiting a person to knowingly or intentionally...distribute, or dispense, or possess
with an intent to...distribute or dispense, a controlled substance.

17. Specifically, the federal government charged the Respondent with 66 counts of
prescribing Adderall to four separate patients, a Schedule II controlled dangerous
substance (“CDS”), outside the usual course of professional practice and without a

legitimate medical purpose. Attachment A, Indictment

5 A review of patient records, reflects that on November 1, 2017, the Respondent conducted
office visits for 5 patients, identified as Patients R, S, T, U, V.

5
